These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3981520)

  • 41. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus.
    Khan F; Siddiqui AA; Ali R
    Scand J Immunol; 2006 Nov; 64(5):507-14. PubMed ID: 17032243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.
    Dijstelbloem HM; Bijl M; Fijnheer R; Scheepers RH; Oost WW; Jansen MD; Sluiter WJ; Limburg PC; Derksen RH; van de Winkel JG; Kallenberg CG
    Arthritis Rheum; 2000 Dec; 43(12):2793-800. PubMed ID: 11145038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Useful laboratory measurements in the management of systemic lupus erythematosus.
    Morrow WJ; Isenberg DA; Todd-Pokropek A; Parry HF; Snaith ML
    Q J Med; 1982; 51(202):125-38. PubMed ID: 6981121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experience of a platelet factor 3 immunoinjury technique in the detection of antiplatelet antibody in systemic lupus erythematosus and other clinical disorders.
    Kutti J; Safai-Kutti S
    Scand J Rheumatol; 1978; 7(1):17-20. PubMed ID: 353972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet associated IgG (PA IgG) in patients with insulin dependent (type 1) diabetes mellitus.
    Triolo G
    J Clin Lab Immunol; 1988 Apr; 25(4):173-5. PubMed ID: 3172176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.
    West SG; Johnson SC
    Ann Intern Med; 1988 May; 108(5):703-6. PubMed ID: 3358571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An enzyme-linked immunosorbent assay for the quantification of serum platelet-bindable IgG.
    Howe SE; Lynch DM; Lynch JM
    Transfusion; 1984; 24(4):348-52. PubMed ID: 6235647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anomalous Raji cell activity related to DNA binding in some patients with autoimmune disease.
    Levinson SS; Goldman J
    Clin Physiol Biochem; 1989; 7(1):18-26. PubMed ID: 2752670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum factors releasing serotonin from normal platelets: relation to the manifestations of systemic lupus erythematosus.
    Ginsberg MH; O'Malley M
    Ann Intern Med; 1977 Nov; 87(5):564-7. PubMed ID: 921084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The thrombocyte link in blood-coagulation homeostasis in patients with systemic lupus erythematosus].
    Vas'kova NG
    Vrach Delo; 1990 Nov; (11):51-3. PubMed ID: 2098984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hematologic syndrome in the clinical picture of systemic lupus erythematosus].
    Potekhina RN; Shilkina NP; Poltyrev AS
    Ter Arkh; 1979; 51(7):64-7. PubMed ID: 494090
    [No Abstract]   [Full Text] [Related]  

  • 56. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus.
    Leone G; Accorra F; Boni P
    Acta Haematol; 1977; 58(4):240-5. PubMed ID: 410226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased platelet serotonin levels in systemic lupus erythematosus.
    Meyerhoff J; Dorsch CA
    Arthritis Rheum; 1981 Dec; 24(12):1495-1500. PubMed ID: 6459785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
    Ahmad F; Solymoss S; Poon MC; Berube C; Sullivan AK
    Br J Haematol; 1996 Jun; 93(3):700-3. PubMed ID: 8652397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of DNA repair of the fibroblasts from patients with systemic lupus erythematosus.
    Ohta A; Morito F; Yamaguchi M
    Jinrui Idengaku Zasshi; 1986 Dec; 31(4):357-64. PubMed ID: 3613242
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical studies on the relationship of vascular complications to platelet functions and plasma factor VIII levels in connective tissue (collagen) diseases.
    Okubo S; Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1255-62. PubMed ID: 3101344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.